Cite
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons – the Swedish AMORIS study
MLA
Van Hemelrijck, Mieke, et al. “Gamma-Glutamyltransferase and Risk of Cancer in a Cohort of 545,460 Persons – the Swedish AMORIS Study.” European Journal of Cancer, vol. 47, no. 13, Sept. 2011, pp. 2033–41. EBSCOhost, https://doi.org/10.1016/j.ejca.2011.03.010.
APA
Van Hemelrijck, M., Jassem, W., Walldius, G., Fentiman, I. S., Hammar, N., Lambe, M., Garmo, H., Jungner, I., & Holmberg, L. (2011). Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons – the Swedish AMORIS study. European Journal of Cancer, 47(13), 2033–2041. https://doi.org/10.1016/j.ejca.2011.03.010
Chicago
Van Hemelrijck, Mieke, Wayel Jassem, Goran Walldius, Ian S. Fentiman, Niklas Hammar, Mats Lambe, Hans Garmo, Ingmar Jungner, and Lars Holmberg. 2011. “Gamma-Glutamyltransferase and Risk of Cancer in a Cohort of 545,460 Persons – the Swedish AMORIS Study.” European Journal of Cancer 47 (13): 2033–41. doi:10.1016/j.ejca.2011.03.010.